Mr. Aman Parmar reports

VANC PHARMACEUTICALS COMMENCES COMMERCIALIZATION IN BRITISH COLUMBIA AND RECEIVES $1,095,728 IN PROCEEDS FROM WARRANT AND OPTION EXERCISES

Vanc Pharmaceuticals Inc. has commenced commercialization of its generic drug portfolio in British Columbia and has started shipping initial purchase orders to pharmacy customers.

"We are excited to have launched sales in our home province of B.C. and over the next two quarters we will work towards listing on other provincial formularies which will open up additional markets in our roll-out strategy," said Arun Nayyar, chief executive officer of Vanc. "We look forward to ramping up sales in [third quarter] 2015 and introducing additional products to our customers."

Further to the company's press release from March 12, 2015, the company has received an additional $1,095,728 from warrant and option exercises, bringing the total proceeds from warrant and option exercises during the first two quarters of the calendar year to $3,095,728.

We seek Safe Harbor.